Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Chemmedchem|October 26, 2018
Targeting Protein Kinase CK1δ with Riluzole: Could It Be One of the Possible Missing Bricks to Interpret Its Effect in the Treatment of ALS from a Molecular Point of View?Maicol Bissaro, Stephanie Federico, Veronica Salmaso, et al.
Mini Reviews in Medicinal Chemistry|December 27, 2005
A2B adenosine receptor antagonists: recent developmentsBarbara Cacciari, Giorgia Pastorin, Chiara Bolcato, et al.
Drug Discovery Today|May 19, 2019
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapySiew L Cheong, Stephanie Federico, Giampiero Spalluto, et al.
RSC Medicinal Chemistry|May 28, 2021
Potent and selective A3 adenosine receptor antagonists bearing aminoesters as heterobifunctional moietiesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Current Topics in Medicinal Chemistry|May 7, 2016
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor AntagonistsSara Redenti, Antonella Ciancetta, Giorgia Pastorin, et al.
Current Medicinal Chemistry|January 11, 2005
Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatmentTatiana Da Ros, Giampiero Spalluto, Maurizio Prato, et al.
Chemmedchem|December 21, 2006
Highlights on the development of A(2A) adenosine receptor agonists and antagonistsGloria Cristalli, Barbara Cacciari, Diego Dal Ben, et al.
Purinergic Signalling|April 12, 2008
Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profileBarbara Cacciari, Chiara Bolcato, Giampiero Spalluto, et al.
Chemical Communications (Cambridge, England)|January 6, 2004
Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modelingStefano Moro, Francesca Deflorian, Giampiero Spalluto, et al.
European Journal of Medicinal Chemistry|December 3, 2019
Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probesStephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Pageof 9